Co-Authors
This is a "connection" page, showing publications co-authored by Cristina Gervasoni and Mario Corbellino.
Connection Strength
0.744
-
Comment on "Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6". Clin Pharmacokinet. 2021 06; 60(6):829-831.
Score: 0.235
-
Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts. Eur J Clin Pharmacol. 2021 05; 77(5):791-792.
Score: 0.229
-
Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose? J Antimicrob Chemother. 2020 09 01; 75(9):2704-2706.
Score: 0.225
-
Does lopinavir really inhibit SARS-CoV-2? Pharmacol Res. 2020 08; 158:104898.
Score: 0.055